Literature DB >> 9066431

Biochemical markers of myocardial injury during cardiac operations.

I Birdi1, G D Angelini, A J Bryan.   

Abstract

The evaluation of myocardial damage in relation to cardiac operation from a clinical and a research perspective is of great importance, particularly for the evaluation of different cardioprotective strategies. Although measurements of serum biochemical markers have often been used, their value has been limited by their lack of sensitivity and specificity in the presence of skeletal muscle damage. A newer range of markers are now available that may reliably indicate both perioperative myocardial infarction, as well as more subtle degrees of subclinical myocyte injury. In this review, the application of biochemical markers for clinical and research purposes during cardiac operation is considered.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9066431     DOI: 10.1016/s0003-4975(96)01275-1

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Assessment of the myocardial protective effect of antegrade warm blood cardioplegia by measuring the release of biochemical markers.

Authors:  K Kawahito; J Mohara; Y Misawa; M Kato; K Fuse
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  The acute cardioprotective effect of glucocorticoid in myocardial ischemia-reperfusion injury occurring during cardiopulmonary bypass.

Authors:  Yavuz Enc; Pelin Karaca; Umut Ayoglu; Gercek Camur; Erol Kurc; Sertac Cicek
Journal:  Heart Vessels       Date:  2006-05       Impact factor: 2.037

3.  Intermediate and high peri-operative cardiac enzyme release following isolated coronary artery bypass surgery are independently associated with higher one-year mortality.

Authors:  N Newall; A Y Oo; N D Palmer; A D Grayson; T J Hine; R H Stables; B M Fabri; D R Ramsdale
Journal:  J Cardiothorac Surg       Date:  2006-08-15       Impact factor: 1.637

Review 4.  Co-morbidities and co-medications as confounders of cardioprotection-Does it matter in the clinical setting?

Authors:  Petra Kleinbongard; Hans Erik Bøtker; Michel Ovize; Derek J Hausenloy; Gerd Heusch
Journal:  Br J Pharmacol       Date:  2020-01-03       Impact factor: 8.739

5.  Plasma levels of growth differentiation factor-15 are associated with myocardial injury in patients undergoing off-pump coronary artery bypass grafting.

Authors:  Zhize Yuan; Haiqing Li; Quan Qi; Wenhui Gong; Cheng Qian; Rong Dong; Yi Zang; Jia Li; Mi Zhou; Junfeng Cai; Zhe Wang; Anqing Chen; Xiaofeng Ye; Qiang Zhao
Journal:  Sci Rep       Date:  2016-06-17       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.